A new trading day began on Monday, with Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock price down -4.51% from the previous day of trading, before settling in for the closing price of $4.21. IRWD’s price has ranged from $3.79 to $15.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 5.56% over the last five years. Meanwhile, its annual earnings per share averaged 102.05%. With a float of $155.76 million, this company’s outstanding shares have now reached $156.35 million.
The firm has a total of 267 workers. Let’s measure their productivity. In terms of profitability, gross margin is 99.6%, operating margin of 28.68%, and the pretax margin is 18.91%.
Ironwood Pharmaceuticals Inc (IRWD) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Ironwood Pharmaceuticals Inc is 2.67%, while institutional ownership is 103.16%. The most recent insider transaction that took place on Nov 18 ’24, was worth 25,030. Before that another transaction happened on Nov 18 ’24, when Company’s Officer proposed sale 12,500 for $4.11, making the entire transaction worth $51,375.
Ironwood Pharmaceuticals Inc (IRWD) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 102.05% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Here are Ironwood Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.74. Likewise, its price to free cash flow for the trailing twelve months is 5.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.02, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.27 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Analysing the last 5-days average volume posted by the [Ironwood Pharmaceuticals Inc, IRWD], we can find that recorded value of 1.45 million was lower than the volume posted last year of 2.91 million. As of the previous 9 days, the stock’s Stochastic %D was 10.96%. Additionally, its Average True Range was 0.31.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 6.94%, which indicates a significant decrease from 7.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.06% in the past 14 days, which was higher than the 89.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.28, while its 200-day Moving Average is $6.91. Now, the first resistance to watch is $4.15. This is followed by the second major resistance level at $4.28. The third major resistance level sits at $4.37. If the price goes on to break the first support level at $3.94, it is likely to go to the next support level at $3.85. Now, if the price goes above the second support level, the third support stands at $3.72.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
With a market capitalization of 658.97 million, the company has a total of 159,739K Shares Outstanding. Currently, annual sales are 442,740 K while annual income is -1,002 M. The company’s previous quarter sales were 91,590 K while its latest quarter income was 3,650 K.
